ALTAMIRA THERAPUTICS LTD SHS PAR $0.002 NEW (NASDAQ:CYTO) Stock Quotes, Forecast and News Summary

ALTAMIRA THERAPUTICS LTD SHS PAR $0.002 NEW Stock (NASDAQ: CYTO) stock price, news, charts, stock research, profile.

Open	-
Close	-
Volume / Avg.	0 / 122.97K
Day Range	- - -
52 Wk Range	0.30 - 3.87
Market Cap	$989.97K
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	23
Short Interest	-
Days to Cover	1

Recent News

Why Lumentum Shares Are Trading Higher By Around 16%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

What's Going On With Altamira Therapeutics Stock?

Altamira Therapeutics shares are trading higher Thursday after the company announced highlights from its NASAR clinical trial with Bentrio nasal spray were published in video format on the social media channels of the allergology journal, "Allergy."

Erica Kollmann

Nasdaq Turns Higher; Akanda Shares Plunge

U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite turning higher on Monday. The Dow traded down 0.37% to 39,331.42 while the NASDAQ rose 0.06% to 16,439.38. The S&P 500 also fell, dropping, 0.12% to 5,227.95.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Open	-
Close	-
Volume / Avg.	0 / 122.97K
Day Range	- - -
52 Wk Range	0.30 - 3.87
Market Cap	$989.97K
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	23
Short Interest	-
Days to Cover	1

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy ALTAMIRA THERAPUTICS LTD SHS PAR $0.002 NEW (CYTO) stock?

You can purchase shares of ALTAMIRA THERAPUTICS LTD SHS PAR $0.002 NEW (NASDAQ:CYTO) through any online brokerage.

View our list of the best stock brokerages

Who are ALTAMIRA THERAPUTICS LTD SHS PAR $0.002 NEW (CYTO) competitors?

There are no as such competitors for ALTAMIRA THERAPUTICS LTD SHS PAR $0.002 NEW.

What is the forecast, or price target, for ALTAMIRA THERAPUTICS LTD SHS PAR $0.002 NEW (CYTO) stock?

There is no analysis for ALTAMIRA THERAPUTICS LTD SHS PAR $0.002 NEW to provide a consensus price target.

What is the current price for ALTAMIRA THERAPUTICS LTD SHS PAR $0.002 NEW (CYTO)?

The stock price for ALTAMIRA THERAPUTICS LTD SHS PAR $0.002 NEW (NASDAQ: CYTO) is $0.262 last updated December 19, 2024 at 7:55 PM EST.

Does ALTAMIRA THERAPUTICS LTD SHS PAR $0.002 NEW (CYTO) pay a dividend?

There are no upcoming dividends for ALTAMIRA THERAPUTICS LTD SHS PAR $0.002 NEW.

When is ALTAMIRA THERAPUTICS LTD SHS PAR $0.002 NEW (NASDAQ:CYTO) reporting earnings?

ALTAMIRA THERAPUTICS LTD SHS PAR $0.002 NEW’s H1 earnings are confirmed for Tuesday, September 24, 2024.

Is ALTAMIRA THERAPUTICS LTD SHS PAR $0.002 NEW (CYTO) going to split?

There is no upcoming split for ALTAMIRA THERAPUTICS LTD SHS PAR $0.002 NEW.

Comments

ALTAMIRA THERAPUTICS LTD SHS PAR $0.002 NEW

ALTAMIRA THERAPUTICS LTD SHS PAR $0.002 NEW (CYTO) Forecast